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TRPC1 Channels Mediate the Nonselective Cation Current and Store-
Operated Calcium Channels in Human Atrial Myocytes
Yan-Hui Zhang, Hai-Ying Sun, Hui-Jun Wu, Gui-Rong Li.
University of Hong Kong, Pokfulam, Hong Kong.
Little information is available in the literature regarding transient receptor
potential (TRP) channels in human atrial myocytes. The present study was de-
signed to investigate whether TRPC channels would mediate the nonselective
cation current reported previously and store-operated Ca2þ entry channels
(SOCs) in human atrial myocytes using approaches of whole-cell patch
voltage-clamp, RT-PCR, Western blot analysis, confocol microscopy, and
co-immunoprecipitation. It was found that the nonselective cation current
was recorded under Kþ-free conditions in human atrial myocytes, and the cur-
rent was inhibited by the nonspecific TRP channel blocker La3þ. The TRPC1
channel activator thapsigargin activated the current, and the effect was sup-
pressed by La3þ and prevented by pipette inclusion of anti-TRPC1 antibody.
In addition, confocol microscopic experiment revealed intracellular Ca2þ tran-
sient mediated by SOCs in human atrial myocytes, which was inhibited or pre-
vented by La3þ. The mRNAs and proteins of STIM1 and Orai1 (components of
SOCs), were abundantly expressed in human atria. Co-immunoprecipitation
analysis demonstrated an interaction of TRPC1 with STIM1 and/or Orai1. In-
terestingly, protein expression of TRPC1 and STIM1, but not Orai1, was upre-
gulated in human atria with atrial fibrillation. Our results indicate that the novel
information that TRPC1 channels not only mediate the nonselective cation cur-
rent, but also is a component of SOCs in human atria. The upregulation of
TRPC1 and STIM1 in human atria with atrial fibrillation may suggest that
TRPC1 channels and SOCs are likely involved in the atrial electrical and/or
structure remodeling in patients with atrial fibrillation.
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TRPC3 was repeatedly discussed as a potential component of store-operated
signaling pathways and is expressed in mast cells, which display the classical
Orai1-mediated CRAC conductance. To elucidate if TRPC3 interferes with
this store-operated conductance, we overexpressed TRPC3 in RBL-2H3 mast
cells and characterized currents activated by passive store depletion (20mM
EGTA). TRPC3 overexpression diminshed the inwardly rectifying CRAC cur-
rent component significantly when free intracellular Mg2þwas kept at a level of
1.6 mM, and this inhibitory effect was more pronounced when free intracellular
Mg2þ was elevated to 8 mM. Moreover, store depletion-induced currents were
completely abolished with expression of a pore-dead mutant of TRPC3
(E630K). By contrast, the potential STIM-binding deficient mutant, E697K/
E698K lacked effects on CRAC current amplitude. Importantly, at low (1.6
mM) intracellular Mg2þ, we observed a reduced Ca2þ selectivity of the store
depletion-activated conductance with appearance of a clearly outward rectify-
ing I-V relation. This nonselective conductance was absent at high (8 mM)
Mg2þ, eliminated by co-expression of the permeation deficient Orai1 E106Q
mutation and displayed sensitivity to the TRPC3 blocker Pyr3 (3 mM) as
well as to the TRPM7 inhibitor NDGA (10 mM). Biophysical and pharmacolog-
ical features of the nonselective conductance, which was activated by store de-
pletion at low (physiologic) intracellular Mg2þ levels, favor the concept of
generation of a unique membrane conductance by TRPC3 overexpression in
RBL cells. Our findings suggest a complex interaction of TRPC3 with Orai1
and probably also TRPM7 in plasma membrane microdomains of mast cells.
Supported by FWF, DK-MCD
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TRPC3 Overexpression Promotes AngiotensinII Induced Cardiac
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TRPC3 was recently suggested as a player in the development of cardiac hyper-
trophy. Little is known about the direct proarrhythmogenic role for TRPC3.
Here we examined the involvement of TRPC3 in cardiac actions of Angioten-
sinII (AngII), a pathophysiologically relevant mediator and activator of GPCR/Gq/TRPC3 signaling, using a TRPC3 transgenic mouse model. A comparison
of AngII actions in the isolated Langendorff perfused heart of TRPC3þ/- (N=5)
and wild-type (WT) mice (N=5) revealed that TRPC3 overexpression strongly
promoted the impairment of cardiac functions by AngII. Administration of An-
gII (100nM) reduced left ventricular pressure (LVP) within 2 min to 64 %, þ
dP/dt to 50 % and - dP/dt to 55 % of control in TRPC3þ/- hearts, while these
functions remained largely unaffected in WT hearts. Simultaneously ECG re-
cordings demonstrated AngII-induced episodes of acute arrhythmogenicity
with ventricular ectopies in all TRPC3þ/- hearts (N=6), whereas rhythm of
WT hearts (N=6) remained unaffected. Changes in Ca2þ transients and sarco-
mere shortening were analyzed in isolated ventricular myocytes. AngII
(100nM) induced a rise in the diastolic Ca2þ level, which was accompanied
by irregular contractions in TRPC3 overexpressing but not in WT myocytes.
Our results demonstrate that AngII modulation of cardiac functions is strictly
dependent on TRPC3 expression and suggest a key role of TRPC channels in
AngII-mediated arrhythmogenicity. Supporteded by FWF, DK-MCD
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We have recently shown that the cation channels TRPC3 and C6 are expressed
in mouse skeletal muscle. Both mRNAs could be detected by RT-PCR and im-
munohistochemical staining revealed the presence of TRPC6 and in part
TRPC3 in the sarcolemma of mouse muscle fibers. OAG, an activator of
TRPC3/C6 and C7, stimulated background Ca2þ influx, supporting the hypoth-
esis of functional expression of TRPC3 and/or C6 in skeletal muscle. TRPC6
could be pharmacologically activated, however, it does not seem to contribute
to background Ca2þ influx, since the specific TRPC6 inhibitor ML-9 was inef-
fective. Here we studied whether the unspecific TRPC channel blocker 2-APB
and/or the specific TRPC3 blocker Pyr3 affect muscular Ca2þ homeostasis. To
investigate divalent cation influx we used single interosseus muscle fibers and
applied the Mn2þ quench technique. Quench of Fura-2 fluorescence was re-
corded in the presence of 0.5 mMMn2þ (excitation at 360 nm). Changes of cy-
toplasmic Ca2þ were measured using Fura-2 and alternate excitation at 340 and
380 nm. 2-APB inhibited background Ca2þ influx by more then 50% (n=44,
p<0.01). The half time of decay of KCl induced calcium transients was as
well significantly influenced by 2-APB (control vs. 2-APB; 3.61 5 0.18 s
vs. 3.18 5 0.15 s; n= 27, 31; p < 0.05). The application of Pyr3 resulted in
a marked inhibition of Fura-2 quench rate (control vs. Pyr3; 6.4 50.6 vs.
2.550.4 %/min; n=46, 46; p<0.01). We conclude that both channels,
TRPC3 and TRPC6 are functional in the sarcolemma of isolated mouse muscle
fibers. However, TRPC6 has no resting activity, but TRPC3 contributes sub-
stantially to the background Ca2þ influx of muscle fibers.
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TRPC3/C6/C7 channels are activated by diacylglycerol (DAG) upon the phos-
pholipase C (PLC) coupled receptor stimulation which results in the breakdown
of phosphoinositides (PIPs). Although the critical function of PIPs on various
ion transporting molecules has been demonstrated, their roles in TRPC3/C6/
C7 channels remain controversial. Here, by ectopical usage of voltage-
sensing PIPs phosphatase (DrVSP), we found that dephosphorylation of PIPs
produces robust inhibition of currents induced by carbachol (CCh), OAG and
RHC80267, for all TRPC3/C6/C7 channels. The strength of inhibition was,
however, variable with the rank order of DrVSP-mediated inhibition (VMI):
C3 < C6 < C7. Pharmacological and molecular interventions most likely sug-
gest that depletion of PI(4,5)P2 is a critical event for VMI of all three channels.
As predicted, when PLC catalytic signal was vigorously activated through over-
expressed muscarinic type-I receptor (M1R), macroscopic kinetics of TRPC
currents were greatly accelerated as similar the rank order of VMI, and it was
simultaneously dismissed or attenuated. Likewise, VMI was rarely detected in
vasopressin-induced TRPC6-like currents from smooth muscle cells (A7r5),
supporting a severe or various degree of PI(4,5)P2 depletion in the physiological
conditions.We also employed simultaneous detection of FRET-based measure-
ment of PI(4,5)P2 and TRPC6 current, confirming that VMI reflects the degree
